DRAG

COM:DRAGARWAL

Dr. Agarwals Eye Hospital

  • Stock

Last Close

4,974.30

25/11 08:47

Market Cap

15.46B

Beta: -

Volume Today

451

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
78.53M
-
90.93M
15.80%
101.25M
11.35%
79.96M
21.03%
67.30M
15.82%
69.13M
2.71%
72.33M
4.64%
65.96M
8.82%
54.72M
17.03%
58.65M
7.18%
78.75M
34.27%
average payables
111.73M
-
134.20M
20.10%
169.74M
26.49%
160.49M
5.45%
156.91M
2.23%
164.22M
4.66%
144.02M
12.30%
156.65M
8.77%
217.48M
38.83%
261.80M
20.38%
292.65M
11.78%
average receivables
70.05M
-
69.40M
0.92%
83.76M
20.69%
88.40M
5.54%
83.77M
5.25%
115.81M
38.25%
136.80M
18.13%
148.66M
8.67%
138.89M
6.57%
108.79M
21.67%
116.60M
7.18%
book value per share
40.95
-
50.55
23.45%
48.48
4.11%
62.56
29.05%
74.59
19.24%
97.00
30.03%
119.36
23.06%
116.30
2.56%
166.32
43.00%
241.15
44.99%
capex per share
-23.05
-
-23.01
0.19%
-35.48
54.20%
-18.14
48.87%
-24.33
34.14%
-52.76
116.83%
-36.47
30.88%
-23.79
34.76%
-99.43
317.89%
-150.72
51.59%
capex to depreciation
-1.77
-
-1.76
0.53%
-1.47
16.60%
-0.98
33.44%
-1.17
19.88%
-2.27
94.36%
-0.81
64.48%
-0.59
27.46%
-2.29
291.44%
-3.51
53.17%
-2.68
23.65%
capex to operating cash flow
-0.90
-
-0.79
12.25%
-0.96
21.90%
-0.42
55.90%
-0.62
45.38%
-0.99
60.63%
-0.44
55.13%
-0.33
25.61%
-0.82
149.74%
-1.02
23.42%
-0.79
22.52%
capex to revenue
-0.09
-
-0.09
3.48%
-0.12
33.41%
-0.06
53.00%
-0.07
29.96%
-0.15
96.26%
-0.10
33.19%
-0.08
18.07%
-0.23
190.21%
-0.27
14.00%
-0.22
15.74%
cash per share
7.30
-
4.02
44.90%
3.96
1.43%
4.86
22.57%
3.89
19.94%
10.08
159.22%
14.36
42.37%
60.57
321.85%
69.30
14.41%
64.28
7.25%
days of inventory on hand
96.18
-
133.42
38.72%
200.39
50.20%
63.74
68.19%
79.77
25.14%
62.99
21.03%
72.81
15.59%
58.56
19.57%
44.84
23.43%
35.93
19.89%
17.00
52.67%
days payables outstanding
137.47
-
201.56
46.62%
370.89
84.01%
144.00
61.17%
190.78
32.49%
148.50
22.16%
123.27
16.99%
200.18
62.40%
200.89
0.35%
159.81
20.45%
55.52
65.26%
days sales outstanding
23.25
-
20.71
10.94%
26.86
29.70%
18.75
30.18%
21.72
15.80%
30.25
39.31%
27.75
8.28%
42.92
54.69%
20.65
51.89%
14.19
31.26%
14.78
4.15%
debt to assets
0.31
-
0.33
6.13%
0.40
20.02%
0.32
20.35%
0.23
29.17%
0.24
5.13%
0.43
80.01%
0.44
1.84%
0.62
41.59%
0.60
3.23%
0.13
78.20%
debt to equity
1.10
-
0.97
11.78%
1.36
39.65%
0.78
42.30%
0.52
33.51%
0.52
0.05%
1.07
105.38%
1.24
15.44%
2.47
100.28%
2.05
17.12%
0.41
80.01%
dividend yield
0.02
-
0.01
43.15%
0.01
35.28%
0.00
57.78%
0.00
0.12%
0.00
24.83%
0.01
142.99%
0.00
97.43%
0.00
76.07%
0.00
5,530.06%
earnings yield
0.07
-
0.10
34.98%
0.00
99.59%
0.05
12,896.99%
0.03
51.48%
0.07
170.63%
0.15
123.23%
-0.01
106.41%
0.07
817.58%
0.09
22.34%
enterprise value
513.81M
-
799.85M
55.67%
1.21B
50.97%
1.62B
33.97%
2.85B
76.03%
1.94B
31.90%
1.44B
25.98%
1.93B
34.59%
5.09B
163.43%
6.35B
24.84%
2.34B
63.12%
enterprise value over ebitda
3.89
-
5.76
48.22%
6.02
4.48%
6.74
11.92%
11.07
64.29%
6.33
42.81%
2.97
53.02%
6.47
117.68%
8.68
34.15%
8.29
4.57%
2.57
68.95%
ev to operating cash flow
4.32
-
5.83
34.95%
6.96
19.35%
8.04
15.56%
15.33
90.77%
7.74
49.56%
3.72
51.95%
5.70
53.44%
8.98
57.43%
9.12
1.63%
2.59
71.62%
ev to sales
0.46
-
0.68
48.42%
0.88
30.62%
1.09
23.16%
1.86
70.54%
1.14
38.37%
0.82
28.45%
1.38
69.00%
2.53
82.95%
2.38
6.12%
0.73
69.14%
free cash flow per share
2.62
-
6.19
136.25%
1.46
76.45%
24.68
1,592.85%
15.18
38.50%
0.58
96.18%
45.70
7,788.40%
48.28
5.64%
21.17
56.15%
-2.60
112.26%
free cash flow yield
0.04
-
0.05
37.97%
0.01
84.90%
0.08
1,000.35%
0.03
67.68%
0.00
94.13%
0.24
15,234.53%
0.15
35.61%
0.03
81.22%
-0.00
109.79%
graham net net
-75.52
-
-71.25
5.66%
-85.68
20.25%
-67.81
20.85%
-71.44
5.35%
-76.61
7.23%
-135.59
77.00%
-121.67
10.27%
-408.25
235.53%
-501.27
22.78%
graham number
69.52
-
117.43
68.92%
9.23
92.14%
148.25
1,506.38%
155.54
4.92%
235.22
51.22%
279.62
18.88%
89.50
67.99%
438.05
389.45%
652.85
49.04%
income quality
3.20
-
2.56
20.04%
-36.05
1,508.82%
2.74
107.61%
2.74
0.06%
2.10
23.24%
2.82
34.15%
-23.55
934.28%
2.35
109.99%
1.89
19.82%
1.95
3.48%
intangibles to total assets
0.01
-
0.01
27.01%
0.00
82.36%
0.01
238.07%
0.04
687.56%
0.02
44.04%
0.27
1,046.04%
0.00
98.55%
0.01
32.85%
0.00
44.36%
0.00
87.58%
interest coverage
2.08
-
3.47
67.12%
1.97
43.13%
4.44
125.10%
5.65
27.30%
8.19
44.82%
3.61
55.85%
2.00
44.70%
6.30
215.18%
8.18
29.89%
8.99
9.84%
interest debt per share
52.63
-
53.94
2.49%
73.85
36.91%
56.15
23.96%
44.41
20.92%
55.51
24.99%
143.49
158.52%
156.76
9.24%
424.64
170.89%
509.23
19.92%
inventory turnover
3.79
-
2.74
27.91%
1.82
33.42%
5.73
214.37%
4.58
20.09%
5.79
26.64%
5.01
13.49%
6.23
24.34%
8.14
30.59%
10.16
24.82%
21.47
111.30%
invested capital
1.10
-
0.97
11.78%
1.36
39.65%
0.78
42.30%
0.52
33.51%
0.52
0.05%
1.07
105.38%
1.24
15.44%
2.47
100.28%
2.05
17.12%
0.41
80.01%
market cap
338.28M
-
587.50M
73.67%
916.50M
56.00%
1.41B
53.85%
2.68B
90.30%
1.74B
35.01%
897.00M
48.56%
1.47B
64.06%
3.44B
133.46%
4.30B
25.22%
net current asset value
-250.75M
-
-229.29M
8.56%
-296.52M
29.32%
-229.94M
22.46%
-229.15M
0.34%
-249.09M
8.70%
-548.00M
120.00%
-564.96M
3.10%
-1.86B
228.95%
-2.30B
23.79%
-2.79B
21.18%
net debt to ebitda
1.33
-
1.53
15.19%
1.45
5.15%
0.87
40.36%
0.64
26.09%
0.64
0.20%
1.12
74.80%
1.54
38.27%
2.82
82.97%
2.68
5.19%
2.57
3.83%
net income per share
5.25
-
12.12
131.13%
0.08
99.36%
15.61
19,895.37%
14.42
7.67%
25.35
75.87%
29.11
14.84%
-3.06
110.51%
51.28
1,775.24%
78.55
53.20%
operating cash flow per share
25.67
-
29.20
13.73%
36.94
26.50%
42.82
15.93%
39.51
7.73%
53.34
34.99%
82.17
54.05%
72.07
12.29%
120.60
67.33%
148.13
22.83%
payables turnover
2.66
-
1.81
31.80%
0.98
45.66%
2.53
157.56%
1.91
24.52%
2.46
28.47%
2.96
20.47%
1.82
38.42%
1.82
0.35%
2.28
25.71%
6.57
187.82%
receivables turnover
15.70
-
17.63
12.29%
13.59
22.90%
19.46
43.23%
16.81
13.64%
12.07
28.22%
13.16
9.03%
8.50
35.35%
17.68
107.88%
25.72
45.48%
24.69
3.99%
research and ddevelopement to revenue
return on tangible assets
0.04
-
0.08
124.47%
0.00
99.43%
0.10
21,369.70%
0.09
14.32%
0.12
39.54%
0.13
9.69%
-0.01
106.96%
0.08
929.24%
0.09
23.08%
0.09
1.49%
revenue per share
243.10
-
251.39
3.41%
290.55
15.58%
316.05
8.77%
326.22
3.22%
360.42
10.49%
372.86
3.45%
296.94
20.36%
427.57
43.99%
568.57
32.98%
roe
0.13
-
0.24
87.22%
0.00
99.33%
0.25
15,393.96%
0.19
22.57%
0.26
35.25%
0.24
6.68%
-0.03
110.79%
0.31
1,271.46%
0.33
5.66%
0.30
9.44%
roic
0.12
-
0.18
49.07%
-0.01
105.98%
0.19
1,901.24%
0.14
26.20%
0.19
34.98%
0.12
38.48%
-0.02
115.82%
0.07
462.97%
0.08
18.40%
0.22
175.54%
sales general and administrative to revenue
0.15
-
0.01
96.50%
0.15
2,861.54%
0.16
3.71%
0.15
3.23%
0.16
4.79%
0.18
8.96%
0.16
10.26%
0.16
0.24%
shareholders equity per share
40.95
-
50.55
23.45%
48.48
4.11%
62.56
29.05%
74.59
19.24%
97.00
30.03%
119.36
23.06%
116.30
2.56%
166.32
43.00%
241.15
44.99%
stock based compensation to revenue
0.00
-
tangible asset value
181.51M
-
231.34M
27.45%
226.60M
2.05%
290.13M
28.04%
316.24M
9.00%
432.11M
36.64%
178.60M
58.67%
540.49M
202.62%
765.20M
41.58%
1.12B
46.63%
1.57B
39.90%
tangible book value per share
40.95
-
50.55
23.45%
48.21
4.63%
61.73
28.04%
67.28
9.00%
91.94
36.64%
38.00
58.67%
115.00
202.62%
162.81
41.58%
238.72
46.63%
working capital
-127.89M
-
-81.09M
36.59%
-106.83M
31.74%
-74.99M
29.81%
-141.60M
88.82%
-54.79M
61.30%
-97.02M
77.07%
-45.26M
53.35%
-33.50M
25.98%
-85.40M
154.93%
-209.40M
145.20%

All numbers in (except ratios and percentages)